In drug discovery, over 90% of drug candidates fail in clinical trials. Traditional models - 2D cell cultures and animal testing - poorly predict human biology, driving huge costs and delays for biotech and pharma.

‍

At Syntopia, we aim to transform how drugs are developed by making advanced, human-relevant in vitro models scalable, accessible, and data-driven.
We build a platform that generate the high-quality datasets needed to power AI, improve predictivity, and accelerate the transition toward New Approach Methodologies.

3D cell culture & organoids
‍Scaffold-based tissue models with long-term viability and functional assays

Innovative microfluidics
‍Pump-free, open format, fully compatible with robotics - enabling high-throughput experiments and large-scale data generation without specialized instruments

Multi-modal readouts
Immunofluorescence imaging, secretome chemical analysis, and RNA sequencing after treatment - delivering a comprehensive view of cell responses

We enable a new generation of drug discovery